Vascular Endothelial Growth Factors

"Vascular Endothelial Growth Factors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A family of angiogenic proteins that are closely-related to VASCULAR ENDOTHELIAL GROWTH FACTOR A. They play an important role in the growth and differentiation of vascular as well as lymphatic endothelial cells.

Descriptor ID	D042442
MeSH Number(s)	D12.644.276.100.800 D12.776.467.100.800 D23.529.100.800
Concept/Terms	Vascular Endothelial Growth Factors Vascular Endothelial Growth Factors VEGFs

Below are MeSH descriptors whose meaning is more general than "Vascular Endothelial Growth Factors".

Chemicals and Drugs [D]
Amino Acids, Peptides, and Proteins [D12]
Peptides [D12.644]
Intercellular Signaling Peptides and Proteins [D12.644.276]
Angiogenic Proteins [D12.644.276.100]
Vascular Endothelial Growth Factors [D12.644.276.100.800]
Proteins [D12.776]
Intercellular Signaling Peptides and Proteins [D12.776.467]
Angiogenic Proteins [D12.776.467.100]
Vascular Endothelial Growth Factors [D12.776.467.100.800]
Biological Factors [D23]
Intercellular Signaling Peptides and Proteins [D23.529]
Angiogenic Proteins [D23.529.100]
Vascular Endothelial Growth Factors [D23.529.100.800]

Below are MeSH descriptors whose meaning is related to "Vascular Endothelial Growth Factors".

Below are MeSH descriptors whose meaning is more specific than "Vascular Endothelial Growth Factors".

Vascular Endothelial Growth Factors
Placenta Growth Factor
Vascular Endothelial Growth Factor A
Vascular Endothelial Growth Factor B
Vascular Endothelial Growth Factor C
Vascular Endothelial Growth Factor D
Vascular Endothelial Growth Factor, Endocrine-Gland-Derived

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Vascular Endothelial Growth Factors" by people in this website by year, and whether "Vascular Endothelial Growth Factors" was a major or minor topic of these publications.

Bar chart showing 36 publications over 17 distinct years, with a maximum of 5 publications in 2001

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	0	1	1
1998	0	4	4
1999	0	2	2
2000	0	4	4
2001	0	5	5
2002	0	4	4
2003	0	2	2
2005	1	0	1
2006	1	1	2
2007	1	0	1
2010	2	0	2
2013	1	1	2
2014	0	1	1
2017	0	1	1
2019	0	1	1
2021	0	1	1
2022	0	2	2

Below are the most recent publications written about "Vascular Endothelial Growth Factors" by people in Profiles.

Patel NA, Acaba-Berrocal LA, Hoyek S, Fan KC, Martinez-Castellanos MA, Baumal CR, Harper CA, Berrocal AM. Practice Patterns and Outcomes of Intravitreal Anti-VEGF Injection for Retinopathy of Prematurity: An International Multicenter Study. Ophthalmology. 2022 12; 129(12):1380-1388.

View in: PubMed
Patel SN, Mokhashi N, Peck TJ, Cai LZ, Salabati M, Soares RR, Hinkle J, Chaudhary V, Kuriyan AE, Cohen MN, Hsu J, Garg SJ. Seasonal and Environmental Variations in Endophthalmitis after Intravitreal Anti-vascular Endothelial Growth Factor Injection: A Six-year Review. Curr Eye Res. 2022 09; 47(9):1288-1293.

View in: PubMed
Hubbard JM, Yin J, Schenk EL, Qin R, Reid JM, Strand C, Fiskum J, Menefee M, Lin G, Doyle LA, Ivy P, Erlichman C, Adjei A, Haluska P, Costello BA. Phase I study of cediranib, an oral VEGFR inhibitor, in combination with selumetinib, an oral MEK inhibitor, in patients with advanced solid malignancies. Invest New Drugs. 2022 02; 40(1):115-123.

View in: PubMed
Russell JF, Albini TA, Berrocal AM, Dubovy SR, Rosenfeld PJ, Smiddy WE, Sridhar J, Townsend JH, Flynn HW. Anti-Vascular Endothelial Growth Factor Therapy for Choroidal Rupture-Associated Choroidal Neovascularization. Ophthalmol Retina. 2020 02; 4(2):226-228.

View in: PubMed
Yl?-Herttuala S, Bridges C, Katz MG, Korpisalo P. Angiogenic gene therapy in cardiovascular diseases: dream or vision? Eur Heart J. 2017 May 07; 38(18):1365-1371.

View in: PubMed
Penon D, Cito L, Giordano A. Novel findings about management of gastric cancer: a summary from 10th IGCC. World J Gastroenterol. 2014 Jul 21; 20(27):8986-92.

View in: PubMed
Nguyen QD, Do DV, Haller JA, Heier JS, Kaiser PK. Putting theories and results into practice: managing cases. Ophthalmology. 2013 May; 120(5 Suppl):S16-22.

View in: PubMed
Haller JA. Current anti-vascular endothelial growth factor dosing regimens: benefits and burden. Ophthalmology. 2013 May; 120(5 Suppl):S3-7.

View in: PubMed
Mabuchi S, Kawase C, Altomare DA, Morishige K, Hayashi M, Sawada K, Ito K, Terai Y, Nishio Y, Klein-Szanto AJ, Burger RA, Ohmichi M, Testa JR, Kimura T. Vascular endothelial growth factor is a promising therapeutic target for the treatment of clear cell carcinoma of the ovary. Mol Cancer Ther. 2010 Aug; 9(8):2411-22.

View in: PubMed
de Nigris F, Crudele V, Giovane A, Casamassimi A, Giordano A, Garban HJ, Cacciatore F, Pentimalli F, Marquez-Garban DC, Petrillo A, Cito L, Sommese L, Fiore A, Petrillo M, Siani A, Barbieri A, Arra C, Rengo F, Hayashi T, Al-Omran M, Ignarro LJ, Napoli C. CXCR4/YY1 inhibition impairs VEGF network and angiogenesis during malignancy. Proc Natl Acad Sci U S A. 2010 Aug 10; 107(32):14484-9.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement